Overview of this study
Why was the research needed?
Researchers are looking for a better way to treat people who have COVID-19 and need hospital care. Before a drug can be approved for people to get, researchers do clinical studies to find out how safe it is and how it works.

What treatments did the participants get?
The participants in this study got either:
- X acalabrutinib and "best supportive care", also called BSC
- X BSC only

What were the results of this study?
The main questions the researchers wanted to answer in this study were:
- X What signs and symptoms did the participants have during this study?
The most common signs or symptoms that the participants had during this study were headache and difficulty sleeping, also called insomnia.
- X Did acalabrutinib when added to BSC help the participants stay alive and breathe without help?
No. Overall, the researchers found that acalabrutinib when added to BSC did not help the participants stay alive and breathe without help.
- X What medical problems did the participants have during this study?
There were 23.3% of participants who got acalabrutinib with BSC who had medical problems that the study doctors thought might be related to acalabrutinib during the study. The most common medical problem was headache.

More details about the results of this study are included later in this summary.

Where can I learn more about this study?
You can find more information about this study on the websites listed on the last page. When a full report of the study results is available, it also can be found on these websites.